Halcyon Health, Inc. — Form D
Halcyon Health, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2020-02-19. The offering totals $2.5M, of which $2.5M was reported sold. Industry: Other Technology.
Offering
- Filed: 2020-02-19
- Form: D
- Accession: 0001231919-20-000010
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $2.5M
- Amount sold: $2.5M
- Investors: 10
- Date of first sale: 2020-02-04
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-360869
Issuer
- Name: Halcyon Health, Inc.
- CIK: 0001803552
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: SPACES, HALCYON HEALTH - 9TH FLOOR, NEW YORK, NY, 10001
- Phone: 5164042286
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Andrew Bryk | Director | New York, NY |
| Joshua Nussbaum | Director | WASSAIC, NY |
| Andrew Bryk | Executive Officer | New York, NY |
| Joshua Nussbaum | Executive Officer | WASSAIC, NY |
| Andrew Bryk | Promoter | New York, NY |
| Joshua Nussbaum | Promoter | WASSAIC, NY |
More